- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02836769
Development and Evaluation of Rehabilitation Consult for Survivors of Head and Neck Cancer (HNC-RC)
Development and Pilot Evaluation of Rehabilitation Consult for Survivors of Head and Neck Cancer
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
A RC for survivors of head and neck cancer (HNC) was developed in collaboration with an Advisory Panel that includes survivors, family members, health care professionals, and health system representatives. This phase of the study aims to conduct a pilot evaluation of the RC using a mixed method, single group study with a convenience sample of approximately 35 survivors of HNC post primary cancer treatment, recruited from the Princess Margaret Cancer Center HNC clinics. In addition to the RC intervention, participants will be required to attend 3 research assessments (pre intervention, post intervention, and 1 month follow-up) that are a combination of face-to-face visits and telephone calls.
Quantitative data analysis will be exploratory and descriptive, and effect sizes will be calculated for all outcomes to help plan for a future, controlled trial. Means, standard deviations, and Cohen's d effect size will be calculated for normally distributed data. For non-normally distributed data, medians, ranges, and a nonparametric effect size r will be calculated. For qualitative analysis, all interviews will be audio recorded, transcribed verbatim, and analyzed using a two-phased, hybrid approach that is both deductive and inductive. Findings will be summarized and reported to the Advisory Panel, who will then make recommendations regarding any additional modifications to the RC. The research team will make final decisions about RC modifications and will finalize a version for future evaluation.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M4N 3M5
- Sunnybrook Health Sciences Centre, Odette Cancer Centre
-
Toronto, Ontario, Canada, M5G 2M9
- University Health Network, Princess Margaret Cancer Centre
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adult survivors of HNC who have completed active treatment (surgery, radiation, chemotherapy or any combination thereof) within 1-18 months.
Exclusion Criteria:
- Lack of English fluency,
- Cognitive impairment, or concurrent major degenerative conditions likely to cause functional deterioration, and
- Known active cancer.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Rehabilitation Consult (RC)
Pilot testing: single group pre-post design
|
The RC was designed to foster key contributors to self management in the participants.
The RC is administered by a rehabilitation professional and consists of an initial one-hour face-to-face consult and follow-up appointment(s) 2-12 weeks later, either telephone or face-to-face.
The initial consult consists of orientation, consultation, goal-setting, teaching cognitive strategies, introduction to online resources/action planning/planning coping responses, review/implementation intentions/scheduling follow-up.
The follow-up consists of a reminder, reorientation, checking of progress on goals and plans, re-planning as necessary, and discharge or scheduling of further follow-up as necessary.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Functional Assessment of Cancer Therapy - Head and Neck (FACT - H&N)
Time Frame: A) 1 week post-intervention, B) 1-2 months post intervention
|
Cancer-specific self-report measure of quality of life, higher scores indicate higher self-reported quality of life.
Scores can range from 0 to 148.
Changes in overall score as well as subsets will be evaluated for evidence of impact of intervention.
|
A) 1 week post-intervention, B) 1-2 months post intervention
|
Change in Medical Outcome Short Form (36) Health Survey - (SF-36)
Time Frame: A) 1 week post-intervention, B) 1-2 months post intervention
|
Self-report quality of life questionnaire.
Higher scores indicate a higher self-reported quality of life.
The Physical Composite Score (PCS) and the Mental Composite Score (MCS) are reported.
Scores range from 0 to 100 for each individual item on the scale.
These scores are then converted into composite totals based on the scoring system provided with the outcome measure.
|
A) 1 week post-intervention, B) 1-2 months post intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Goal Performance, Satisfaction, and Self-efficacy
Time Frame: A) 1 week post-intervention, B) 1-2 months post intervention
|
Participants completed the Brief Rehabilitation Assessment for Survivors Of Head And Neck Cancer (BRASH), a self report tool where participants rate their current performance, satisfaction with self-selected rehab goals, and rate their confidence in their ability to achieve each goal.
Higher scores indicate greater self-reported, performance, satisfaction, and self-efficacy.
Scores for each of confidence, performance, and satisfaction can range from 0 to 100.
Each category is then compared to itself and the change calculated by subtracting the earlier score from the latter.
|
A) 1 week post-intervention, B) 1-2 months post intervention
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Sara McEwen, PhD, Sunnybrook Research Institute, St. John's Rehab Program
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 246-2013
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Study Data/Documents
-
Study Protocol
Information comments: Publication of the initial project protocol
-
Clinical Study Report
Information comments: Publication based on findings from focus groups used to create the intervention in this study
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Head and Neck Neoplasms
-
Robert FerrisAmgenCompletedHead and Neck Cancer | Cancer of Head and Neck | Head Cancer | Neck Cancer | Neoplasms, Head and Neck | Cancer of the Head and Neck | Cancer of Neck | Upper Aerodigestive Tract Neoplasms | Neck Neoplasms | Cancer of the Head | Cancer of the Neck | UADT Neoplasms | Cancer of Head | Head Neoplasms | Head, Neck Neoplasms | Neoplasms, Head and other conditionsUnited States
-
Assiut UniversityRecruitingHead and Neck Cancer | Head and Neck Neoplasms | Cancer of Head and Neck | Neoplasms, Head and Neck | Cancer of the Head and NeckEgypt
-
IRCCS Policlinico S. MatteoNestlé Health Science Spain; Akern SrlCompletedHead-neck CancerItaly
-
University of California, San FranciscoCompleted
-
AZ Sint-Jan AVRecruiting
-
IntraGel TherapeuticsNot yet recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingHead and Neck CarcinomaUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisActive, not recruiting
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Completed
-
Jonsson Comprehensive Cancer CenterWithdrawnHead and Neck CarcinomaUnited States
Clinical Trials on Rehabilitation Consult (RC)
-
University Health Network, TorontoCompleted
-
NYU Langone HealthThe Rainer Arnhold FoundationCompletedCoronary Artery Disease | Hypertension | Obesity | Diabetes | Peripheral Arterial Disease | Hyperlipidemia | PrediabetesUnited States
-
Radboud University Medical CenterUnknown
-
University of VermontNeurocrine BiosciencesRecruitingDrug-Induced Movement DisorderUnited States
-
Turtle Health, Inc.WithdrawnFertility RiskUnited States
-
University of VirginiaNamrita OdackalCompletedPremature Birth | Prenatal StressUnited States
-
MaineHealthCompletedNeonatal EncephalopathyUnited States
-
MaineHealthCompletedNeonatal EncephalopathyUnited States
-
Centre hospitalier de l'Université de Montréal...Terminated
-
Ottawa Hospital Research InstituteCompletedMortality | Aged | Epidemiology | SURGICAL PROCEDURES, OPERATIVECanada